NIGRO, Gerardo
 Distribuzione geografica
Continente #
EU - Europa 3.986
NA - Nord America 3.681
AS - Asia 679
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
AF - Africa 2
Totale 8.363
Nazione #
US - Stati Uniti d'America 3.671
IE - Irlanda 1.355
FR - Francia 581
GB - Regno Unito 458
UA - Ucraina 387
IT - Italia 377
DE - Germania 361
CN - Cina 301
SG - Singapore 270
SE - Svezia 177
GR - Grecia 117
FI - Finlandia 111
TR - Turchia 50
BE - Belgio 19
HK - Hong Kong 18
KR - Corea 14
CZ - Repubblica Ceca 13
IN - India 10
CA - Canada 9
JP - Giappone 6
NL - Olanda 6
EU - Europa 5
RU - Federazione Russa 5
AU - Australia 3
BR - Brasile 3
ES - Italia 3
NO - Norvegia 3
PL - Polonia 3
AL - Albania 2
AT - Austria 2
CO - Colombia 2
ID - Indonesia 2
QA - Qatar 2
RO - Romania 2
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
JO - Giordania 1
KE - Kenya 1
LT - Lituania 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
TH - Thailandia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 8.363
Città #
Dublin 1.354
Santa Clara 888
Jacksonville 657
Chandler 518
Princeton 192
Singapore 176
Medford 156
Bremen 148
Roxbury 146
Ann Arbor 88
Wilmington 82
Boardman 73
Beijing 66
San Mateo 63
Caserta 56
Cambridge 45
Des Moines 44
Woodbridge 44
Naples 29
Jinan 25
New York 25
Nanjing 22
Düsseldorf 20
Munich 19
Nanchang 19
Mountain View 18
Brussels 17
Milan 16
Hong Kong 15
Norwalk 15
Helsinki 14
Houston 14
Brno 13
Guangzhou 13
Seoul 13
Hebei 12
Redwood City 12
Lanzhou 11
Shenyang 11
Zhengzhou 11
Marano Di Napoli 10
Napoli 10
Taizhou 10
Changsha 9
Lappeenranta 9
Rome 9
Tianjin 9
Haikou 8
Hangzhou 8
Ercolano 7
Taiyuan 7
Auburn Hills 6
Paris 6
Shanghai 6
Ashburn 5
Bacoli 5
Ningbo 5
Spring City 5
Cerro Maggiore 4
Changchun 4
Florence 4
London 4
Los Angeles 4
Lubbock 4
Nuremberg 4
Philadelphia 4
Avellino 3
Gunzenhausen 3
Hanover 3
Jessheim 3
Nocera Superiore 3
Ottawa 3
Pagani 3
Palermo 3
Pelago 3
Prato 3
Rostock 3
Seattle 3
Tappahannock 3
Toronto 3
Venice 3
Acerra 2
Afragola 2
Atlanta 2
Bath 2
Bengaluru 2
Brighton 2
Brookings 2
Cagliari 2
Castelfidardo 2
Columbus 2
Dearborn 2
Doha 2
Fairfield 2
Frankfurt am Main 2
Gragnano 2
Groningen 2
Grumo Nevano 2
Herk-de-stad 2
Jakarta 2
Totale 5.409
Nome #
Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes 88
Cardiomyopathies associated with Muscular Dystrophies 86
Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy 77
Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy 76
La variabilità del ciclo R-R come indice predittivo di effetto sul ritmo cardiaco in soggetti professionalmente esposti ai campi elettromagnetici ELF 76
Novel mutations in LMNA A/C gene and associated phenotypes 75
A longitudinal study on BIO14.6 hamsters with dilated cardiomyopathy: Micro-echocardiographic evaluation 73
The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population. 72
Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. 71
Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. 71
Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. 70
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 70
The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. 69
Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up. 69
Increased heterogenity of ventricular repolarization in obese nonhypertensive children 69
The effect of aortic coarctation surgical repair on QTc and JTc dispersion in severe aortic coarctation newborns: a short-term follow-up study. 69
The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. 68
Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex. 67
Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. 67
Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study 66
Ambulatory dynamic Holter monitoring: a practical guide to appropriate use and reporting in clinical cardiology 66
Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. 65
Ventricular fibrillation induced by coagulating mode bipolar electrocautery during pacemaker implantation in Myotonic Dystrophy type 1 patient. 64
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 64
The Impact of Selection Criteria of Obese Patients on Evaluation of Heart Rate Variability Following Bariatric Surgery Weight Loss 64
Familial dilated cardiomyopathy associated with the typical dystrophin BMD mutation. Report on two additional cases 64
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies 64
Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study. 63
Which parameters describe the electrophysiological properties of successful slow pathway RF ablation in patients with common atrioventricular nodal reentrant tachycardia? 63
Ginkgo biloba: an ancient tree with new arrhythmic side effects. 63
Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1. 63
Risk of arrhythmias in MYotonic Dystrophy: trial design of the RAMYD study 62
ST-segment displacement in Duchenne muscular dystrophy: myocardial necrosis or apoptosis? 62
The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope. 62
Usefulness of Heart Rate Variability as a predictor of sudden cardiac death in muscular dystrophies 62
Disease rescue and increased lifespan in a model of cardiomyopathy and muscular dystrophy by combined AAV treatments 62
Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death 61
Idiopathic left ventricular tachycardia: Evidence of a his bundle 'bystander' participation 61
Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement. 61
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 61
Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients? 60
Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. 59
P dispersion: a new electrocardiographic parameter to evaluate the risk of atrial arrhythmias in Emery-Dreifuss muscular dystrophies 59
Evaluation of the antioxidant response in the plasma of healthy or hypertensive subjects after short-term exercise 57
Evaluation of Becker cardiomyopathy by Vest investigation 57
P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. 57
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population 57
Apixaban in a morbid obese patient with atrial fibrillation: A clinical experience using the plasmatic drug evaluation 57
Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation 56
Advances in basic and clinical research in laminopathies. 56
Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results 56
HETEROGENEITY OF VENTRICULAR REPOLARIZATION IN SEVERE AORTIC COARCTATION NEWBORNS 55
Evaluation of cardiac and respiratory involvement in sarcoglycanopathies 55
Atrial Septal Aneurysms and Supraventricular Arrhythmias: The Role of Atrial Electromechanical Delay. 55
Ischemic heart disease therapy in the elderly: Risk/benefit ratio 55
Heart involvement in Emery-Dreifuss muscular dystrophies: new parameters to detect early atrial fibrosis and vulnerability 55
Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols 54
The QT dispersion in the risk stratification of sudden death in Becker patients 54
Diagnosis and Management of Atrial Fibrillation by Primary Care Physicians in Italy : A Retrospective, Observational Analysis. 54
Evaluation of thyroid dysfunction in patients with paroxysmal atrial fibrillation 53
Risk of arrhythmia in type I Myotonic Dystrophy: the role of clinical and genetic variables 52
Is the value of QT dispersion a valid method to foresee the risk of sudden death? A study in Becker patients 52
Arrhythmic risk in Steinert Disease 52
Arrhythmias and sudden cardiac death in beta-thalassemia major patients: Noninvasive diagnostic tools and early markers 52
Anaesthesia and Rare Neuromuscular Diseases 51
Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results 51
La variabilità del ciclo R-R come indice predittivo di effetto sul ritmo cardiaco in soggetti professionalmente esposti a campi elettromagnetici ELF. Atti del 64° Congresso Nazionale SIMLII 51
Management of cardiac involvement in muscular dystrophies: Paediatric versus adult forms 51
Physical Activity Measured by Implanted Devices Predicts Atrial Arrhythmias and Patient Outcome: Results of IMPLANTED (Italian Multicentre Observational Registry on Patients With Implantable Devices Remotely Monitored) 50
Atrial Fibrillation and Malignancy: The Clinical Performance of Non-Vitamin K Oral Anticoagulants-A Systematic Review 49
Autonomic nervous system modulation before the onset of sustained atrioventricular nodal reentry tachycardia. 48
Nonvitamin K Antagonist Oral Anticoagulants Use in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves/Prior Surgical Valve Repair: A Multicenter Clinical Practice Experience 48
P3.14 New AAVs for the muscle gene therapy in sarcoglycan deficient animals 48
Heart rate variability, obesity, and bariatric-induced weight loss: the importance of selection criteria 47
Cardiopulmonary resuscitation in pectus excavatum patients: is it time to say more? 47
Rischio aritmico nella Distrofia Miotonica tipo 1 (Studio RAMYD): Risultati preliminari ad un anno 47
Effects of defibrillation shock in patients implanted with a subcutaneous defibrillator: a biomarker study 47
DUAL PATHWAY INHIBITION WITH RIVAROXABAN AND ASPIRIN REDUCES INFLAMMATORY BIOMARKERS IN ATHEROSCLEROSIS 46
Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patient 46
Role of electrophysiological evaluation for the best device choice to prevent sudden cardiac death in patients with Myotonic Dystrophy Type 1 and Emery Dreifuss Muscular Dystrophy 46
Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study 46
Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study 46
Use of a lower dosage liver-Detargeted AAV vector to prevent hamster muscular dystrophy. 45
Efficacy and safety of dabigatran in patients with atrial fibrillation scheduled for transoesophageal echocardiogram-guided direct electrical current cardioversion: a prospective propensity score-matched cohort study 45
Cardiac resynchronization improves heart failure in one patient with Myotonic Dystrophy type 1. A case report. 44
Interazione tra campi elettromagnetici ELF e ritmo cardiaco in macchinisti di veicoli a trazione elettrica: ricerca di un indice predittivo di rischio aritmico 44
Cardiac involvement in laminopathies–short invited review 44
Arrhythmic risk evaluation in myotonic dystrophy: the importance of selection criteria and methodological approach 44
Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients 44
Evaluation of the effectiveness of the permanent biventricular pacing or implantable cardioverter-defibrillator in Becker patients with dilated cardiomyopathy and advanced heart failure 42
Superselective cannulation of coronary sinus branch with telescopic system during left ventricular lead placement 42
Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdown 42
Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients 42
Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients 41
ICD role in preventing sudden cardiac death in Emery-Dreifuss muscular dystrophy with preserved myocardial function: 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy. 41
DOES HIGH PERCENTAGE OF RIGHT VENTRICULAR PACING HAVE AN INFLUENCE ON PAROXYSMAL ATRIAL FIBRILLATION INCIDENCE IN MYOTONIC DYSTROPHY TYPE 1 PATIENTS? 41
Cardiomyopathies: diagnosis of types and stages 41
Monitoring of markers suitable for the prognosis of the cardiomyopathies in muscle dystrophies 41
Is Heart Rate Variability a prognostic indicator in patients with Dystrophia Myotonica type 1? 41
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence 41
Totale 5.665
Categoria #
all - tutte 43.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020486 0 0 0 0 0 0 190 48 131 43 51 23
2020/20211.107 86 4 97 90 235 11 148 101 15 121 160 39
2021/20221.336 68 26 52 48 403 4 10 36 44 192 96 357
2022/20232.302 223 43 24 175 264 160 7 111 1.207 21 37 30
2023/2024850 55 39 38 65 344 32 15 21 4 17 60 160
2024/20251.204 19 27 15 73 505 562 3 0 0 0 0 0
Totale 8.787